Shopping Cart
- Remove All
Your shopping cart is currently empty
Phenazopyridine hydrochloride (Pyridium) is used orally as a urinary tract analgesic. Side effects of phenazopyridine hydrochloride administration can include nausea, interference with the oxygen-carrying capacity of red blood cells (methemoglobinemia), hemolytic anemia as well as renal and hepatic toxicity. It is reasonably anticipated to be a human carcinogen.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 mg | $38 | In Stock | |
| 100 mg | $47 | In Stock | |
| 200 mg | $66 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $50 | In Stock |
| Description | Phenazopyridine hydrochloride (Pyridium) is used orally as a urinary tract analgesic. Side effects of phenazopyridine hydrochloride administration can include nausea, interference with the oxygen-carrying capacity of red blood cells (methemoglobinemia), hemolytic anemia as well as renal and hepatic toxicity. It is reasonably anticipated to be a human carcinogen. |
| In vitro | Phenazopyridine directly inhibits the mechanical sensitivity of Aδ-fibers in the bladders of normal rats. |
| In vivo | Phenazopyridine enhances cell viability, strengthens neuronal cell differentiation, synchronizes the state of cell differentiation, and reduces the number of non-neuronal and undifferentiated cells. |
| Synonyms | Urodine, Pyridium, Phenazopyridine HCl |
| Molecular Weight | 249.7 |
| Formula | C11H12ClN5 |
| Cas No. | 136-40-3 |
| Smiles | Cl.Nc1ccc(\N=N\c2ccccc2)c(N)n1 |
| Relative Density. | 1.2645 g/cm3 (Estimated) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 10 mg/mL (40.05 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.